Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health
- PMID: 25635583
- PMCID: PMC4431624
- DOI: 10.1097/MOP.0000000000000192
Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health
Abstract
Purpose of review: Children are more susceptible to exposures in utero and during early childhood that may result in developmental problems and chronic diseases. Novel discoveries in the field of molecular epidemiology that can help explain susceptibility to exposures and disease will be demonstrated using the multifunctional enzyme paraoxonase 1 (PON1) as an example.
Recent findings: The broad PON1 variability in humans, partly due to differences in genetics and age, can confer differential susceptibility because this enzyme can detoxify organophosphate pesticides and has antioxidant properties. Epigenetics plays a significant role in the mediation of the effects of environmental exposure on human health and is hypothesized to be a major contributing factor to the early-life origins of adult disease. Studies highlighted in this review demonstrate the relationship of PON1 polymorphisms with microRNA binding in addition to a link between DNA methylation in the transcriptional regulatory region with changes in PON1 enzyme levels. Other important methodologies such as ancestry informative markers and lactonase activity can enhance studies involving PON1.
Summary: This PON1 model demonstrates that integrating genetic and epigenetic factors, as well as other novel methodologies, can improve our understanding of important susceptibility factors linked to pediatric disease.
Conflict of interest statement
None
Figures


Similar articles
-
Epigenomics, gestational programming and risk of metabolic syndrome.Int J Obes (Lond). 2015 Apr;39(4):633-41. doi: 10.1038/ijo.2015.13. Epub 2015 Feb 2. Int J Obes (Lond). 2015. PMID: 25640766 Review.
-
Associations of PON1 and genetic ancestry with obesity in early childhood.PLoS One. 2013 May 3;8(5):e62565. doi: 10.1371/journal.pone.0062565. Print 2013. PLoS One. 2013. PMID: 23658746 Free PMC article.
-
Recent developments on the role of epigenetics in obesity and metabolic disease.Clin Epigenetics. 2015 Jul 11;7:66. doi: 10.1186/s13148-015-0101-5. eCollection 2015. Clin Epigenetics. 2015. PMID: 27408648 Free PMC article. Review.
-
Interaction between prenatal pesticide exposure and a common polymorphism in the PON1 gene on DNA methylation in genes associated with cardio-metabolic disease risk-an exploratory study.Clin Epigenetics. 2017 Apr 5;9:35. doi: 10.1186/s13148-017-0336-4. eCollection 2017. Clin Epigenetics. 2017. PMID: 28396702 Free PMC article.
-
A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease.OMICS. 2021 Jan;25(1):38-51. doi: 10.1089/omi.2020.0160. Epub 2020 Dec 11. OMICS. 2021. PMID: 33306925 Free PMC article.
Cited by
-
Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown.Arch Toxicol. 2017 Aug;91(8):2939-2952. doi: 10.1007/s00204-016-1926-1. Epub 2017 Jan 9. Arch Toxicol. 2017. PMID: 28070599 Free PMC article. Review.
-
The shared mother-child epigenetic signature of neglect is related to maternal adverse events.Front Physiol. 2022 Aug 24;13:966740. doi: 10.3389/fphys.2022.966740. eCollection 2022. Front Physiol. 2022. PMID: 36091392 Free PMC article.
-
The Relationship between Cancer and Paraoxonase 1.Antioxidants (Basel). 2022 Mar 31;11(4):697. doi: 10.3390/antiox11040697. Antioxidants (Basel). 2022. PMID: 35453382 Free PMC article. Review.
-
Cholesterol reduction and macrophage function: role of paraoxonases.Curr Opin Lipidol. 2017 Oct;28(5):397-402. doi: 10.1097/MOL.0000000000000444. Curr Opin Lipidol. 2017. PMID: 28742600 Free PMC article. Review.
-
A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease.Clin Epigenetics. 2021 Aug 13;13(1):158. doi: 10.1186/s13148-021-01142-1. Clin Epigenetics. 2021. PMID: 34389043 Free PMC article.
References
-
- Li HL, Liu DP, Liang CC. Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med. 2003 Dec;81(12):766–79. - PubMed
-
- Costa L, Cole T, Jansen K, Furlong CE. Paraoxonase (PON1) and Organophosphate Toxicity. In: Mackness B, editor. The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism. Springer; 2008. pp. 209–20.
-
- Ferretti G, Bacchetti T, Masciangelo S, et al. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects. Obesity (Silver Spring) 2010 Jun;18(6):1079–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous